Video  |  Chinese  |  English | RSS
Home Our Company Innovative Products News Career i Heart Contact Us

JW Medical Systems (JWMS), established in the beautiful coastal city of Weihai, Shandong, China in 2003. It is a subsidiary of Biosensors International and is an enterprise integrated with multiple innovative solutions and extraordinary achievements in the field of the interventional healthcare. Integrating investment domestically and globally, JWMS is an international company focusing on the R & D, manufacturing and marketing of high-tech interventional products. Upon construction and development over the years, JWMS has set up representative offices in Beijing, Shanghai, Guangzhou, Shenyang and Xi'an. Today nearly 1000 employees dedicate their talents and energy on providing cutting-edge solutions in the field of interventional healthcare.

History

2003

Foundation of JWMS in Weihai, Shandong, China

2004

Granted with the certificates of TUV, ISO 9001 and ISO 13485 authentication

2005

General Secretary Mr. Hu Jintao visited JWMS

2005

Granted with SFDA registration certificate and officially launching the first biodegradable DES product in China

2006

Mr. Ma Kai, former Director of National Development and Reform Commission visited JWMS

2006

Officially launching "CREATE" study, the first large-scale multi-center clinical trial in China

2008

Granted with the financial support from National Development and Reform Commission for research on the "Industrialization of Biodegradable Polymer Coronary Stent" as the flagship project

2008

Rewarded with Weihai Top Science and Technology Award

2009

Officially launching "EVOLUTION" study, a prospective, randomized, controlled, paralleled multi-center clinical trial

2011

Authorized as "High-tech Enterprise"

2011

JWMS Industrial Park was settled in Weihai, Shandong, China

2011

Celebrating the 5th Anniversary of EXCEL Biodegradable DES product launch

2011

Achieved "National Award for Technological Invention" 

2012

JWMS Industrial Park got GMP certified by government 

2012

Became a wholly-owned subsidiary of Biosensors International, one of the world’s top 100 medical enterprises

2013

The 10th Anniversary Ceremony of JW Medical Systems

2014

The new generation DES prospective multicenter clinical trial launched

2015

12th Anniversary Ceremony of JW Medical Systems

2016

The encouraging result of CREDIT II study was released at the TCT conference in the United States

2017

JWMS  products were selected into the excellent domestic medical equipment product catalog

2017

Awarded the Best International Institute partner

2017

EXCROSSSAL, a new generation of biodegradable polymer drug eluting stent, was officially launched

2018

Became a member of Bluesail Medical Co., Ltd.

2018

Sales amount of EXCEL stent has reached 2 million

2018

Allegra TAVI (transcatheter aortic valve implantation) system was successfully implanted for the first time in the world, officially entering the field of structural heart disease.